Glow Peptides · Research Journal

What Is KLOW Peptide? The Four Components

Glow Peptides Research Team · 2026-09-17

For research use only. Not for human or veterinary use, diagnostic use, or in any therapeutic application.

KLOW is a research preparation holding four peptides freeze-dried together: KPV, GHK-Cu, BPC-157 and TB-500. It is a market name, not a chemical one. BPC-157 names one exact molecule; KLOW names a specific four-component combination, and in this catalog that combination is the KLOW four-peptide research vial under catalog code KL80. This page sets out what each of the four names refers to, what the code encodes, and what a lot document for a four-component vial has to show.

What is KLOW peptide, and what does the name refer to?

KLOW is a label the market settled on for a particular combination. No standards body issues it, no database holds a record under it, and nothing about the word tells you what is in the container. That is not a criticism of the name. It is simply what the name is, and knowing that is the first useful thing, because it means the vial has to be identified by something else.

Two strings on the label do that work. The first is the catalog code, a short letter block for the material followed by a number, which for this preparation is KL80. The code identifies the product and is stable across every batch, which is exactly why it cannot identify a batch. The second is the lot number, which changes with every production run and is the only string that resolves to one specific run, and therefore to whatever document has been published for it.

So the translation a reader needs is this: KLOW is the market word, KL80 is the catalog word, and the lot number is the word that connects a vial in your hand to a document you can read.

The four components, by name and identity

Only BPC-157 returns a record titled with its own name. The other three each need explaining, and the reasons are set out below the table.

Those are the records an identity result should be reconciled against, rather than a single number every certificate must print. KPV can be finished with either of two slightly different chemical endings, and the expected mass shifts by about one unit between them, so the document has to state which ending it reports. What stays true is the coarser check: a document naming one compound and reporting the mass of an entirely different one has an internal contradiction, and no purity figure anywhere else on the page fixes it.

Two naming traps in that component list

Both are worth knowing before you try to look anything up, because both will send a careful person to the wrong record.

KPV does not resolve under its own abbreviation. PubChem's canonical title for the record is Msh (11-13), because the tripeptide corresponds to residues 11 to 13 of a longer hormone. Searching the database for the three letters does not reliably return it and will return an unrelated organic acid instead. The CID is what resolves; the abbreviation is not. What the compound is on its own is set out in what KPV is.

GHK-Cu does not resolve to one record either. GHK on its own is the free tripeptide glycyl-L-histidyl-L-lysine at about 340.38. GHK-Cu is that tripeptide complexed with copper, and PubChem carries at least four records for the copper-bound form, with different formulas, different charges and different masses. One of them is titled simply GHK-Cu and is a dimer at about 744.3, so searching the abbreviation does not settle the question either.

Both are real records and neither is a typo. Prezatide copper, CID 71587328, is C₁₄H₂₃CuN₆O₄⁺ at about 402.92, carrying a positive charge. Copper tripeptide, CID 139035031, is C₁₄H₂₁CuN₆O₄⁻ at about 400.90, carrying a negative one. The copper is part of the species in both, not a trace additive.

The arithmetic works for each of them and the two answers differ, which is the point. Copper weighs about 63.5. Against the positively charged record, the cation, at 402.92 the gap from the free tripeptide is about 62.5, which is copper less one hydrogen. Against the negatively charged one, the anion, at 400.90 the gap is about 60.5, which is copper less three hydrogens. So a GHK-Cu mass on a document only means something once the record it was taken from is named. A component list that writes GHK-Cu against a mass of 340 has mixed the complex with the free peptide, and that figure is describing something else again.

What co-lyophilized means, and why it matters here

The correct term for how these four are put together is co-lyophilized: freeze-dried together into a single cake in a single sealed vial, rather than supplied as four vials to be handled separately.

That is a manufacturing fact with a documentation consequence. Because the four arrive as one cake, there is no point at which a reader can inspect them individually, so everything they can know about the proportions and the quality of each one has to come off a document. A four-vial set would let you read four certificates. A co-lyophilized vial gives you one, and that one has to carry four components' worth of information.

What the KL80 code tells you, and what it does not

KL80 is built from a letter block for the material followed by a number. On this vial that number matches the strength of 80 mg that the lot record for 260320HPKL80 states, read here as a nominal total across all four components, and on the GLOW vial under code GL70 the number matches its own stated strength the same way. On these two products the number tracks the nominal total.

The convention is not uniform across the catalog, so do not infer a strength from a code. A related encapsulated product carries the closely related code KL80-C, with its own stated composition, and its own lot record states an entirely different strength on a different basis. Read the strength off the lot record rather than off the code.

One further limit on the code is worth stating plainly: catalog codes are internal to each supplier and are not an industry standard. No body issues them and there is no registry where two suppliers' codes could be reconciled, so another supplier's KL80 need not mean what this one does. The code tells you what a container is supposed to hold within one company's own scheme, and nothing about origin.

Why purity is stated per component

The phrase on the product page is per component, by HPLC, and it is load-bearing rather than decorative.

HPLC is a standard laboratory separation test, and the purity it reports is a share. The instrument separates what is in the sample and the result expresses the target as a proportion of everything detected. On a vial holding one material that is a clean question: there is one peak you want and everything else is something you do not.

Put four materials in one vial and the question stops being clean, because three of the four things that would otherwise count as everything else are intended contents. They are not impurities. A figure reported against the mixture as a whole would say very little, since a weak component can be masked by three strong ones. Stating the specification per component says instead that each material is held to the threshold individually, before they are combined.

The second half of that sentence carries as much weight as the first. A catalog specification is not a measured lot result. A specification is a floor the supplier undertakes to clear on a released lot. A lot result is what an analysis found in one sample of one batch on one date. The two are different kinds of statement, and only the second describes the container you are holding.

What a lot document for a four-component vial has to show

The general discipline is the same as for any research material: a lot number matching the vial in front of you, the laboratory named rather than described, the analytical method stated alongside any figure, and a report date belonging to that batch. The field-by-field walkthrough is in how to read a peptide certificate of analysis.

Three things are specific to a vial holding four materials.

An identity result for each named component, not one for the vial. On KLOW that means four results, matched against the masses in the table above and against whatever the document states for TB-500.

Purity reported per component. A single combined figure does not establish that any individual material cleared the threshold.

Quantities per component, if the proportions matter to you. This is the one question neither the catalog code nor any purity figure answers. Four materials could each be extremely pure and still be combined in a split you did not expect, because purity states what fraction of a material is the intended compound and says nothing about how much of it is present.

Published lot records for this catalog are listed on the lot document directory, each at its own address. The lot record for KLOW lot 260320HPKL80 lists the batch and links the certificate itself as a PDF. The record and the certificate are two different documents and the distinction matters, because the record page states plainly that it asserts no laboratory, report identifier, analytical method or result for the lot. The certificate is where those live, so that is the file to open before attributing any result to a batch. Lot document availability varies by compound and by batch, so check the specific lot rather than assuming coverage.

What this page deliberately does not cover

Most pages returned for this question move quickly to what the combination may do, how long to run it, what to expect and what to pair it with. Those subjects are absent here on purpose, and saying so is more useful than leaving the gap unexplained.

Glow Peptides supplies cataloged materials for laboratory research only. The materials are not drugs, supplements, cosmetics or medical devices, and they are not intended for human or veterinary use. This page gives no dosing, administration, reconstitution, duration, combination or protocol guidance, states no expected outcomes and makes no claim about what these materials do; those questions are outside what a supplier of research materials should answer. What is in scope, and what this page covers, is composition, strength, purity, analytical methods, handling, storage and documentation.

Frequently asked questions

What is KLOW peptide?

KLOW is a research preparation holding four peptides freeze-dried together: KPV, GHK-Cu, BPC-157 and TB-500. It is a market name rather than a chemical one, so no database holds a record under the word KLOW. In this catalog the vial carries catalog code KL80; a related encapsulated product sits under KL80-C with its own stated composition. Each of the four components has its own separate identity.

What does KL80 mean on the label?

KL80 is the catalog code. The letter block identifies the material and on this vial the number gives the nominal total peptide content of the vial in milligrams, which the lot record for 260320HPKL80 states as a strength of 80 mg. It is not 80 mg of each, which would imply 320 mg in the vial, and the split between components is not encoded in the code at all. The convention is not uniform across the catalog either: the related encapsulated product under KL80-C carries its own lot record stating an entirely different strength on a different basis. Read the strength off the lot record rather than the code.

Why can I not find KPV in a chemical database?

Because PubChem files it under a different title. The canonical name on the record is Msh (11-13), since the tripeptide corresponds to residues 11 to 13 of a longer hormone. Searching the bare abbreviation does not reliably return it and will return an unrelated organic acid instead. The CID, 125672, is what resolves. The formula is C16H30N4O4 at about 342.43.

Why is GHK-Cu listed with more than one mass?

Two reasons, and they compound. First, GHK on its own is the free tripeptide glycyl-L-histidyl-L-lysine, PubChem CID 73587, at about 340.38, which is a different thing from the copper-bound form. Second, PubChem carries more than one record for the copper-bound form itself: prezatide copper, CID 71587328, C14H23CuN6O4+ at about 402.92, and copper tripeptide, CID 139035031, C14H21CuN6O4- at about 400.90. Copper weighs about 63.5, so the gap from the free tripeptide is about 62.5 against the positively charged form, which is copper less one hydrogen, and about 60.5 against the negatively charged form, which is copper less three hydrogens. A GHK-Cu mass only means something once the record it came from is named.

What does a purity specification "per component" mean on a blend?

It means each material in the vial is held to the threshold individually, rather than the mixture being assessed as a whole. On a co-lyophilized preparation the other three components are supposed to be present, so they are not impurities and a single combined figure would say very little, since a weak component can be masked by three strong ones. It is also a specification rather than a measurement: a floor the supplier undertakes to clear, not what an analysis found in your batch.

What should a lot document for a four-component vial show?

Start by separating the two documents. The lot record page lists the batch and links the certificate, and it states plainly that it asserts no laboratory, report identifier, method or result itself. The certificate is the file to read. On it: a lot number matching the vial in front of you, the laboratory named rather than described, the analytical method stated alongside any figure, and a report date belonging to that batch. Three things are specific to a blend: an identity result for each named component rather than one for the vial, purity reported per component, and quantities per component if the proportions matter to you. That last one is the question neither the catalog code nor any purity figure answers.

Sources

• PubChem, National Library of Medicine, National Institutes of Health. Compound records read 1 October 2026 and re-checked 2 October 2026: BPC-157 CID 9941957; KPV CID 125672, held under the title "Msh (11-13)"; glycyl-L-histidyl-L-lysine CID 73587; prezatide copper CID 71587328; copper tripeptide CID 139035031; and the dimer record titled GHK-Cu, CID 133697840. Formulas, masses and charges taken directly from those records.
• Glow Peptides live product pages for the KLOW vial and for the related KL80-C encapsulated product, read 1 October 2026, re-checked 5 October 2026, for the KLOW composition and the per-component wording of the purity specification. Each product's composition is its own page's statement. The catalog codes KL80 and KL80-C are carried in the pages' body text and product markup.
• Glow Peptides published lot document directory and the individual lot record for 260320HPKL80, read 1 October 2026 and re-checked 2 October 2026. The lot record page states that no laboratory, report identifier, method or result is asserted there; the certificate it links is what must be read before any result is attributed to that lot. The directory itself carries separate wording, that document availability does not establish analytical approval.
• The 62.5 and 60.5 unit differences between the free tripeptide and the two copper-bound records, and their attribution to copper less one hydrogen and copper less three hydrogens respectively, were computed from CIDs 73587, 71587328 and 139035031 above.

For research use only. Not for human or veterinary use, diagnostic use, or any therapeutic application.

More research articles · Browse research peptides